Skip to main navigation Skip to search Skip to main content

A licence to cure: when there is sufficient evidence of quality, efficacy, and safety, the cheapest product should be prescribable

    Research output: Contribution to journalEditorial

    1 Citation (Scopus)
    Original languageEnglish
    Article numberh1723
    Number of pages2
    JournalBMJ
    Volume350
    DOIs
    Publication statusPublished - 1 Apr 2015

    Cite this